Teratogenic Risk Impact and Mitigation (TRIM): Study Protocol for the Development of a Decision Support Tool to Prioritize Medications for Risk Mitigation

• Almut Gertrud WintersteinUniversity of Florida
• Celeste L. Y. EwigUniversity of Florida
• Yanning WangUniversity of Florida
• Nicole E. SmolinskiUniversity of Florida
• Gita A. ToyserkaniUnited States Food and Drug Administration
• Cynthia LaCivitaUnited States Food and Drug Administration
• Leila G. LackeyUnited States Food and Drug Administration
• Sara L. EggersUnited States Food and Drug Administration
• Esther H. ZhouUnited States Food and Drug Administration
• Vakaramoko DiabyOtsuka (United States)
• Amir Sarayani
• Thuy Nhu ThaiHarvard University
• Judith C. MaroHarvard University
• Sonja A. RasmussenJohns Hopkins University